谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Effectiveness and Safety of Ustekinumab for Moderate to Severely Active Crohn's Disease: Results from an Early Access Program in Brazil.

Julio Maria Fonseca Chebli,Rogerio Serafim Parra,Cristina Flores,Antonio Carlos Moraes,Rodrigo Bremer Nones,Tarcia Nogueira Ferreira Gomes, Ana Maria Bravo Perdomo,Gustavo Scapini,Cyrla Zaltman

Journal of clinical medicine（2022）

引用 1|浏览17
暂无评分
关键词
biological products,ustekinumab,crohn’s disease,early access program
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要